These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32650161)

  • 1. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
    Saito S; Takagi H; Wakasa Y; Ozawa K; Takaiwa F
    Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.
    Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Takaishi S; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S
    Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T; Fujinami K; Ishikawa R; Tateno M; Tahara Y; Okumura Y; Ohta H; Miyazaki H; Taniguchi M
    Int Arch Allergy Immunol; 2015; 168(1):32-43. PubMed ID: 26524293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.
    Takaishi S; Saito S; Endo T; Asaka D; Wakasa Y; Takagi H; Ozawa K; Takaiwa F; Otori N; Kojima H
    Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Rice-Seed-Based Oral Allergy Vaccines Containing Hypoallergenic Japanese Cedar Pollen Allergen Derivatives for Immunotherapy.
    Takaiwa F; Yang L; Takagi H; Maruyama N; Wakasa Y; Ozawa K; Hiroi T
    J Agric Food Chem; 2019 Nov; 67(47):13127-13138. PubMed ID: 31682438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergy.
    Wakasa Y; Takagi H; Watanabe N; Kitamura N; Fujiwara Y; Ogo Y; Hayashi S; Yang L; Ohta M; Thet Tin WW; Sekikawa K; Takano M; Ozawa K; Hiroi T; Takaiwa F
    PLoS One; 2015; 10(3):e0120209. PubMed ID: 25774686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens.
    Fukuda K; Ishida W; Harada Y; Wakasa Y; Takagi H; Takaiwa F; Fukushima A
    Br J Ophthalmol; 2015 May; 99(5):705-9. PubMed ID: 25563761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced anaphylactic potential of denatured pullulan-conjugated Cry j 1.
    Utsumi D; Sugawara T; Hashida K; Yasuhara Y; Fujinami K; Lund K; Ohashi-Doi K
    Int Immunopharmacol; 2021 Oct; 99():108026. PubMed ID: 34358858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies.
    Takaiwa F; Yang L
    Transgenic Res; 2014 Aug; 23(4):573-84. PubMed ID: 24638148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice.
    Fukuda K; Ishida W; Harada Y; Wakasa Y; Takagi H; Takaiwa F; Fukushima A
    Allergol Int; 2018 Jan; 67(1):119-123. PubMed ID: 28676431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of Japanese cedar pollinosis and sensitization to the pollen allergens among Japanese monkeys in a troop.
    Sakaguchi M; Kobayashi C; Inouye S; Saito S; Hirahara K; Shiraishi A; Konaka A; Yamada T; Nigi H
    Immunology; 1999 Jul; 97(3):522-5. PubMed ID: 10447776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of japanese cedar pollinosis and sensitization to the pollen allergens among Japanese monkeys in a troop.
    Sakaguchi M; Kobayashi C; Inouye S; Saito S; Hirahara K; Shiraishi A; Konaka A; Yamada T; Nigi H
    Immunology; 1999 Jun; 97(2):348-51. PubMed ID: 10447752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
    Yang L; Suzuki K; Hirose S; Wakasa Y; Takaiwa F
    Plant Biotechnol J; 2007 Nov; 5(6):815-26. PubMed ID: 17714439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
    Fujimura T; Kawamoto S
    Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
    Osada T; Okano M
    Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
    Murakami D; Kubo K; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic rice accumulating modified cedar pollen allergen Cry j 2 derivatives.
    Suzuki K; Yang L; Takaiwa F
    J Biosci Bioeng; 2012 Feb; 113(2):249-51. PubMed ID: 22055918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.